Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “Phase I trial of lorlatinib in combination with topotecan/cyclophosphamide in children with ALK-driven refractory or relapsed neuroblastoma: A new approaches to neuroblastoma therapy consortium study.”.
Yaël P. Mossé, Kimberly Kayser, Yueh‐Yun Chi, Marc Chioda, Holger Thurm +14 more
Seong‐Hyeon Kim, Kathleen Ingman, Van Huynh, Heather Huszti, Kimberly Kayser +13 more